The upcoming Summer Olympics and management meetings caused Wells Fargo analysts to provide their two cents on sports apparel giant Nike Inc (NYSE:NKE) …
It’s not all bullish in the biotech sector. Analysts remains bearish and neutral on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Gilead Sciences, Inc.
Wells Fargo analyst David Wong was out with a research note on shares of Advanced Micro Devices, Inc.(NASDAQ:AMD), reiterating an Outperform rating with a valuation range of $4.
Wells Fargo analyst Jim Birchenough maintained an Underperform rating on shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), with a valuation range of $5.
Weakness among semiconductor stocks is weighing on the Nasdaq today, with the Philadelphia Semiconductor Index falling by 1.6.
In a research report issued yesterday, Wells Fargo analyst Jim Birchenough reiterated an Underperform rating on shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), with a valuation range of $5.
The most anticipated report of the entire earnings season will be released after today’s closing bell. Wells Fargo analyst Maynard Um and BMO Capital analyst Tim …
It’s been a long road to recovery for Valeant Pharmaceuticals Intl Inc (NYSE:VRX), which doesn’t seem to be getting any easier as the …
Technology analysts explain why they are bullish on social media leader Facebook Inc (NASDAQ:FB) and e-commerce giant Amazon.com, Inc.
As the earnings season winds down, analysts are now hailing some of the last reporters, which are BlackBerry Ltd (NASDAQ:BBRY) and Micron Technology, …
